There’s a Shortage of Antidepressant Zoloft and Its Generic Version amid Coronavirus, FDA Says
The FDA announced a shortage of the antidepressant Zoloft and its generic version, sertraline, as the coronavirus pandemic has led to an increase in reports of depression and anxiety in the U.S.
The FDA posted the announcement of the shortage to its website Friday, estimating that it will last about 60 days.
The short supply of the commonly used antidepressant comes just days after researchers at Johns Hopkins University found an increase in psychological distress reported among U.S. adults during the pandemic.
